Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CRP (C-reactive protein) and IL-6 (interleukin-6) may be markers for type 2 diabetes:

This article was originally published in Clinica

Executive Summary

Elevated levels of two inflammatory proteins, C-reactive protein (CRP) and interleukin-6 (IL-6), may indicate an increased risk of type 2 diabetes, according to US researchers. Following suggestions that inflammation plays a role in the development of type 2 diabetes, Paul Ridker and colleagues at Harvard Medical School in Boston, Massachusetts, studied the levels of CRP and IL-6 in 27,628 women and followed them over a four-year period. 188 women developed type 2 diabetes, and among these, baseline levels of CRP and IL-6 were significantly higher than among those who did not.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT072165

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel